Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search General Information

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 72 > >>
EC Number General Information Commentary Reference
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target contents of L-tryptophan and monoamines and their metabolites are measured in the serum and hippocampus of kynurenine 3-monooxygenase KO mice. It is investigated whether antidepressants improve the depressive-like behaviors in kynurenine 3-monooxygenase KO mice. KO mice show antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions via abnormality of kynurenine metabolism with good validities as model for major depressive disorder 741802
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target inhibition of the enzyme shows benefit in neurodegenerative diseases such as Huntington’s and Alzheimer’s. It is a target for acute pancreatitis multiple organ dysfunction syndrome 743342
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target kynurenine represents a branch point of the kynurenine pathway, being converted into the neurotoxin 3-hydroxykynurenine via kynurenine monooxygenase, neuroprotectant kynurenic acid, and anthranilic acid. As a result of this branch point, kynurenine monooxygenase is an attractive drug target for several neurodegenerative and/or neuroinflammatory diseases, especially Huntington's, Alzheimer's, and Parkinson's diseases 742349
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target the enzyme is a clinical candidate for the treatment of acute pancreatitis 743067
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target the enzyme is a potential drug target for treatment of neurodegenerative disorders such as Huntington's and Alzheimer's diseases 742081
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target the enzyme is a potential therapeutic target for neurodegenerative and neurologic disorders 742478
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9drug target the enzyme is a therapeutic target in several disease states, including Huntington's disease 743747
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9evolution KMO belongs to a family of NAD(P)H-dependent flavin monooxygenase (FMO). KMO has one dicucleotide binding domain, which simply categorizes it as a Class A flavoprotein aromatic hydroxylase 765436
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9evolution KMO is a class A external flavoprotein aromatic hydroxylase (FAH). This class of enzymes uses the isoalloxazine ring of FAD to mediate the delivery of electrons from singlet state NADPH to the molecular oxygen ground state triplet in order to promote subsequent hydroxylation of singlet state molecules 764027
Show all pathways known for 1.14.13.9Display the word mapDisplay the reaction diagram Show all sequences 1.14.13.9malfunction adaptive—and possibly regulatory-changes in mice with a targeted deletion of kynurenine 3-monooxygenase (Kmo-/-) are investigated kynurenine 3-monooxygenase-deficient mice are characterized using six behavioral assays relevant for the study of schizophrenia. Elimination of kynurenine 3-monooxygenase in mice is associated with multiple gene and functional alterations that appear to duplicate aspects of the psychopathology of several neuropsychiatric disorder 742039
Results 1 - 10 of 72 > >>